{"url_path":"/sec/btsg/8-k/2026-06-12/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1865782/0001193125-26-269360-index.html","accession_number":"0001193125-26-269360","cik":"0001865782","ticker":"BTSG","issuer_name":"BrightSpring Health Services, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1865782/0001193125-26-269360-index.html","primary_entity_key":"0001865782","primary_entity_name":"BrightSpring Health Services, Inc."},"word_count":130,"has_tables":true,"body_markdown":"## Item 7.01 Regulation FD Disclosure.\n\nIn connection with the appointment of Dr. Shah to the Board, the Company issued a press release on June 12, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01.\n\nThe information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated by specific reference in any such filing."}